Cryostimulation therapy in postcovid patients

Cryostimulation therapy in postcovid patients - CIPCO

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00038164

Enrollment

Registered

2025-10-27

Start date

2025-12-15

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U09.9

Interventions

Group 1: 9 x 3 min with -120 grade cryotherapy, first minute -20 grade, 3 weeks, Mon, Wed and Frid each Group 2: 9 x 3 min with -20 grade, 3 weeks, Mon, Wed and Frid each

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: resident of Berlin, diagnosed with PostCovid-Syndrom, relevant daily living impairment

Exclusion criteria

Exclusion criteria: cold agglutinines positive, previous cryostimulation therapy, stimulation devices

Design outcomes

Primary

Measure	Time frame
fatigue reduction, T1 before treatment, T2 after treatment, T3 after 3 months, T4 after 12 months (hand dynanometer, 6-min-walking-test, FACIT4-Test)	—

Secondary

Measure	Time frame
depression	—

Countries

Germany

Contacts

Public ContactAndreas Kopf

Charité

andreas.kopf@charite.de+49 30 450 651 621

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026